161 related articles for article (PubMed ID: 38866666)
1. The tumor-driven antibody-mediated immune response in cancer.
Paparoditis P; Shulman Z
Curr Opin Immunol; 2024 Jun; ():102431. PubMed ID: 38866666
[TBL] [Abstract][Full Text] [Related]
2. Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced
Garaud S; Zayakin P; Buisseret L; Rulle U; Silina K; de Wind A; Van den Eyden G; Larsimont D; Willard-Gallo K; Linē A
Front Immunol; 2018; 9():2660. PubMed ID: 30515157
[TBL] [Abstract][Full Text] [Related]
3. Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers.
Playoust E; Remark R; Vivier E; Milpied P
Cell Mol Immunol; 2023 Sep; 20(9):1040-1050. PubMed ID: 37419983
[TBL] [Abstract][Full Text] [Related]
4. Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?
Fridman WH; Sibéril S; Pupier G; Soussan S; Sautès-Fridman C
Semin Immunol; 2023 Jan; 65():101703. PubMed ID: 36481358
[TBL] [Abstract][Full Text] [Related]
5. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
6. B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?
Lauss M; Donia M; Svane IM; Jönsson G
Clin Cancer Res; 2022 May; 28(9):1751-1758. PubMed ID: 34965949
[TBL] [Abstract][Full Text] [Related]
7. B Cell Orchestration of Anti-tumor Immune Responses: A Matter of Cell Localization and Communication.
Kinker GS; Vitiello GAF; Ferreira WAS; Chaves AS; Cordeiro de Lima VC; Medina TDS
Front Cell Dev Biol; 2021; 9():678127. PubMed ID: 34164398
[TBL] [Abstract][Full Text] [Related]
8. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
N J; J T; Sl N; Gt B
Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
[TBL] [Abstract][Full Text] [Related]
9. CD86
Wennhold K; Thelen M; Lehmann J; Schran S; Preugszat E; Garcia-Marquez M; Lechner A; Shimabukuro-Vornhagen A; Ercanoglu MS; Klein F; Thangarajah F; Eidt S; Löser H; Bruns C; Quaas A; von Bergwelt-Baildon M; Schlößer HA
Cancer Immunol Res; 2021 Sep; 9(9):1098-1108. PubMed ID: 34155067
[TBL] [Abstract][Full Text] [Related]
10. Participation of B cell in immunotherapy of cancer.
Chandnani N; Gupta I; Mandal A; Sarkar K
Pathol Res Pract; 2024 Mar; 255():155169. PubMed ID: 38330617
[TBL] [Abstract][Full Text] [Related]
11. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
[TBL] [Abstract][Full Text] [Related]
13. Role of B Cells in Responses to Checkpoint Blockade Immunotherapy and Overall Survival of Cancer Patients.
Kim SS; Sumner WA; Miyauchi S; Cohen EEW; Califano JA; Sharabi AB
Clin Cancer Res; 2021 Nov; 27(22):6075-6082. PubMed ID: 34230025
[TBL] [Abstract][Full Text] [Related]
14. Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer.
Yuan H; Mao X; Yan Y; Huang R; Zhang Q; Zeng Y; Bao M; Dai Y; Fang B; Mi J; Xie Y; Wang X; Zhang H; Mo Z; Yang R
J Transl Med; 2024 Jan; 22(1):48. PubMed ID: 38216927
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
Maibach F; Sadozai H; Seyed Jafari SM; Hunger RE; Schenk M
Front Immunol; 2020; 11():2105. PubMed ID: 33013886
[TBL] [Abstract][Full Text] [Related]
16. B cells in the balance: Offsetting self-reactivity avoidance with protection against foreign.
Young C; Lau AWY; Burnett DL
Front Immunol; 2022; 13():951385. PubMed ID: 35967439
[TBL] [Abstract][Full Text] [Related]
17. Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures.
Magara T; Nakamura M; Nojiri Y; Yoshimitsu M; Kano S; Kato H; Morita A
Front Oncol; 2023; 13():1106434. PubMed ID: 37081973
[TBL] [Abstract][Full Text] [Related]
18. Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer.
Qin M; Hamanishi J; Ukita M; Yamanoi K; Takamatsu S; Abiko K; Murakami R; Miyamoto T; Suzuki H; Ueda A; Hosoe Y; Horie A; Yamaguchi K; Mandai M
Cancer Immunol Immunother; 2022 Jun; 71(6):1431-1442. PubMed ID: 34689225
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.
Nicholas NS; Apollonio B; Ramsay AG
Biochim Biophys Acta; 2016 Mar; 1863(3):471-482. PubMed ID: 26554850
[TBL] [Abstract][Full Text] [Related]
20. T follicular helper cells in cancer, tertiary lymphoid structures, and beyond.
Cui C; Craft J; Joshi NS
Semin Immunol; 2023 Sep; 69():101797. PubMed ID: 37343412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
